The PPARδ-stimulated hepatic fatty accumulation we observed in our study was accompanied by substantial weight loss, if not preceded, with exceptions of PPARα-KO and PPARδ-KO mice fed GW501516, where neither weight loss nor liver steatosis was observed. The gene discussed is PPARD; the disease is fatty liver disease.